Home > Insider Trading > Filing (0001213900-24-113655)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1101026	Zivo Bioscience Inc.	ZIVO	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
919484	E Mark Strome	1688 Meridian Avenue, Suite 727 Miami Beach FL 33139	No	No	Yes	No
936711	Strome Investment Management Lp	C/O Strome Group, Inc. 13535 Ventura Blvd., Ste C-525 Sherman Oaks CA 91423	No	No	Yes	No
1724136	Strome Group, Inc.	13535 Ventura Blvd., Ste C-525 Sherman Oaks CA 91423	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-12-26	75,000	$20.19	398,683	No	4	P	Indirect	By entity

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By entity

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Purchase Warrant	Acquisiton	2024-12-26	7,500	$0.00	7,500	$20.19

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
44,171	2024-12-26	2029-12-26	No	4	P	Indirect

Footnotes

The reported securities are held by Strome Mezzanine Fund II, LP ("SMF II). Strome Investment Management, LP is the general partner of SMF II. Strome Group, Inc. is the general partner of Strome Investment Management, LP. Mark E. Strome is the President and CEO of Strome Group, Inc. Mr. Strome, Strome Investment Management, LP and Strome Group, Inc. (together, the "Reporting Persons") may be deemed to share voting and investment power for the shares held by SME II. The Reporting Persons disclaim beneficial ownership of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), except to the extent of their pecuniary interest therein. This filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any equity securities reported herein.